{
    "xml": "<topic id=\"PHP3954\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/proguanil-hydrochloride\" basename=\"proguanil-hydrochloride\" title=\"PROGUANIL HYDROCHLORIDE\">\n<title>PROGUANIL HYDROCHLORIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_339\" namespace=\"/interactions/list-of-drug-interactions/antimalarials/proguanil\">Proguanil</xref>\n</p>\n<data name=\"vtmid\">16970001</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_709441655\" title=\"Biguanides\">Biguanides</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP60951\" outputclass=\"indicationsAndDose\" rev=\"1.51\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of malaria</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Up to 11 weeks (body-weight up to 6 kg)</p>\n<p>25&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 3&#8211;11 months (body-weight 6&#8211;9 kg)</p>\n<p>50&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;3 years (body-weight 10&#8211;16 kg)</p>\n<p>75&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 4&#8211;7 years (body-weight 16&#8211;25 kg)</p>\n<p>100&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 8&#8211;12 years (body-weight 25&#8211;45 kg)</p>\n<p>150&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 13&#8211;17 years (body-weight 46 kg and above)</p>\n<p>200&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60878\" outputclass=\"unlicensedUse\" rev=\"1.11\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p>Proguanil doses in BNF Publications may differ from those in product literature.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60943\" outputclass=\"interactions\" rev=\"1.7\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (proguanil).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60901\" outputclass=\"sideEffects\" rev=\"1.17\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Constipation</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">mild gastric intolerance</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Cholestasis</ph>; <ph outputclass=\"sideEffect\">hair loss</ph>; <ph outputclass=\"sideEffect\">skin reactions</ph>; <ph outputclass=\"sideEffect\">vasculitis</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Mouth ulcers</ph>; <ph outputclass=\"sideEffect\">stomatitis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60932\" outputclass=\"pregnancy\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Benefit of prophylaxis in malaria outweighs risk.</p>\n<p>Adequate folate supplements should be given to mother.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61071\" outputclass=\"breastFeeding\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Amount in milk probably too small to be harmful when used for malaria prophylaxis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60914\" outputclass=\"renalImpairment\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Use half normal dose if estimated glomerular filtration rate 20&#8211;60 mL/minute/1.73m<sup>2</sup>.</p>\n<p>Use one-quarter normal dose on alternate days if estimated glomerular filtration rate 10&#8211;20 mL/minute/1.73m<sup>2</sup>.</p>\n<p>Use one-quarter normal dose once weekly if estimated glomerular filtration rate less than 10 mL/minute/1.73m<sup>2</sup>.</p>\n<p>Increased risk of haematological toxicity.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>100&#8239;mg once daily if eGFR 20&#8211;60&#8239;mL/minute/1.73m<sup>2</sup>.</p>\n<p>50&#8239;mg on alternate days if eGFR 10&#8211;20&#8239;mL/minute/1.73m<sup>2</sup>.</p>\n<p>50&#8239;mg once weekly if eGFR less than 10&#8239;mL/minute/1.73m<sup>2</sup>. </p>\n<p>Increased risk of haematological toxicity.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61096\" outputclass=\"directionsForAdministration\" rev=\"1.11\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Tablet may be crushed and mixed with food such as milk, jam, or honey just before administration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60923\" outputclass=\"patientAndCarerAdvice\" rev=\"1.12\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Warn travellers about <b>importance</b> of avoiding mosquito bites, <b>importance</b> of taking prophylaxis regularly, and <b>importance</b> of immediate visit to doctor if ill within 1 year and <b>especially</b> within 3 months of return.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60851\" outputclass=\"nationalFunding\" rev=\"1.9\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>National funding/access decisions</title>\n<body>\n<section outputclass=\"nonNHS\">\n<title>NHS restrictions</title>\n<sectiondiv>\n<p>Drugs for malaria prophylaxis not prescribable on the NHS; health authorities may investigate circumstances under which antimalarials are prescribed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60836\" outputclass=\"exceptionsToLegalCategory\" rev=\"1.11\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>Exceptions to legal category</title>\n<body>\n<section>\n<sectiondiv>\n<p>Can be sold to the public provided it is licensed and labelled for the prophylaxis of malaria. </p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3954-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/proguanil-hydrochloride\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral solution, oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76488\" title=\"Tablet\" namespace=\"/drugs/proguanil-hydrochloride/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP98624\" namespace=\"/drugs/chloroquine-with-proguanil\" title=\"CHLOROQUINE WITH PROGUANIL\" count=\"1\" rel=\"backlink\">CHLOROQUINE WITH PROGUANIL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP97237\" namespace=\"/guidance/adverse-reactions-to-drugs\" title=\"Adverse reactions to drugs\" count=\"1\" rel=\"backlink\">Adverse reactions to drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78098\" namespace=\"/treatment-summaries/antimalarials\" title=\"Antimalarials\" count=\"3\" rel=\"backlink\">Antimalarials</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78102\" namespace=\"/treatment-summaries/malaria-prophylaxis\" title=\"Malaria, prophylaxis\" count=\"4\" rel=\"backlink\">Malaria, prophylaxis</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_339\" namespace=\"/interactions/list-of-drug-interactions/antimalarials/proguanil\" title=\"Proguanil\" count=\"1\" rel=\"link\">Proguanil</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76488\" namespace=\"/drugs/proguanil-hydrochloride/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP3954",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/proguanil-hydrochloride",
    "basename": "proguanil-hydrochloride",
    "title": "PROGUANIL HYDROCHLORIDE",
    "interactants": [
        {
            "id": "bnf_int_339",
            "label": "Proguanil"
        }
    ],
    "vtmid": "16970001",
    "drugClassification": [
        "Biguanides"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of malaria",
                        "html": "Prophylaxis of malaria"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "25 mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>25&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "up to 11 weeks (body-weight up to 6 kg)"
                    },
                    {
                        "textContent": "50 mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>50&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "3&#8211;11 months (body-weight 6&#8211;9 kg)"
                    },
                    {
                        "textContent": "75 mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>75&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "1&#8211;3 years (body-weight 10&#8211;16 kg)"
                    },
                    {
                        "textContent": "100 mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>100&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "4&#8211;7 years (body-weight 16&#8211;25 kg)"
                    },
                    {
                        "textContent": "150 mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>150&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "8&#8211;12 years (body-weight 25&#8211;45 kg)"
                    },
                    {
                        "textContent": "200 mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>200&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "13&#8211;17 years (body-weight 46 kg and above)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "200 mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>200&#8239;mg once daily, dose to be started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "textContent": "Proguanil doses in BNF Publications may differ from those in product literature.",
                "html": "<p>Proguanil doses in BNF Publications may differ from those in product literature.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (proguanil).",
                "html": "<p>Appendix 1 (proguanil).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Constipation",
                        "html": "Constipation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "mild gastric intolerance",
                        "html": "mild gastric intolerance",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Cholestasis",
                        "html": "Cholestasis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hair loss",
                        "html": "hair loss",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "skin reactions",
                        "html": "skin reactions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "vasculitis",
                        "html": "vasculitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Mouth ulcers",
                        "html": "Mouth ulcers",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "stomatitis",
                        "html": "stomatitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Benefit of prophylaxis in malaria outweighs risk.\n\nAdequate folate supplements should be given to mother.",
                "html": "<p>Benefit of prophylaxis in malaria outweighs risk.</p><p>Adequate folate supplements should be given to mother.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Amount in milk probably too small to be harmful when used for malaria prophylaxis.",
                "html": "<p>Amount in milk probably too small to be harmful when used for malaria prophylaxis.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Use half normal dose if estimated glomerular filtration rate 20&#8211;60 mL/minute/1.73m2.\n\nUse one-quarter normal dose on alternate days if estimated glomerular filtration rate 10&#8211;20 mL/minute/1.73m2.\n\nUse one-quarter normal dose once weekly if estimated glomerular filtration rate less than 10 mL/minute/1.73m2.\n\nIncreased risk of haematological toxicity.",
                "html": "<p>Use half normal dose if estimated glomerular filtration rate 20&#8211;60 mL/minute/1.73m<sup>2</sup>.</p><p>Use one-quarter normal dose on alternate days if estimated glomerular filtration rate 10&#8211;20 mL/minute/1.73m<sup>2</sup>.</p><p>Use one-quarter normal dose once weekly if estimated glomerular filtration rate less than 10 mL/minute/1.73m<sup>2</sup>.</p><p>Increased risk of haematological toxicity.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "100 mg once daily if eGFR 20&#8211;60 mL/minute/1.73m2.\n\n50 mg on alternate days if eGFR 10&#8211;20 mL/minute/1.73m2.\n\n50 mg once weekly if eGFR less than 10 mL/minute/1.73m2.\n\nIncreased risk of haematological toxicity.",
                "html": "<p>100&#8239;mg once daily if eGFR 20&#8211;60&#8239;mL/minute/1.73m<sup>2</sup>.</p><p>50&#8239;mg on alternate days if eGFR 10&#8211;20&#8239;mL/minute/1.73m<sup>2</sup>.</p><p>50&#8239;mg once weekly if eGFR less than 10&#8239;mL/minute/1.73m<sup>2</sup>. </p><p>Increased risk of haematological toxicity.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Tablet may be crushed and mixed with food such as milk, jam, or honey just before administration.",
                "html": "<p>Tablet may be crushed and mixed with food such as milk, jam, or honey just before administration.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Warn travellers about importance of avoiding mosquito bites, importance of taking prophylaxis regularly, and importance of immediate visit to doctor if ill within 1 year and especially within 3 months of return.",
                "html": "<p>Warn travellers about <b>importance</b> of avoiding mosquito bites, <b>importance</b> of taking prophylaxis regularly, and <b>importance</b> of immediate visit to doctor if ill within 1 year and <b>especially</b> within 3 months of return.</p>"
            }
        ]
    },
    "nationalFunding": {
        "nonNHS": [
            {
                "type": "nonNHS",
                "textContent": "Drugs for malaria prophylaxis not prescribable on the NHS; health authorities may investigate circumstances under which antimalarials are prescribed.",
                "html": "<p>Drugs for malaria prophylaxis not prescribable on the NHS; health authorities may investigate circumstances under which antimalarials are prescribed.</p>"
            }
        ]
    },
    "exceptionsToLegalCategory": {
        "exceptionsToLegalCategory": [
            {
                "type": "exceptionsToLegalCategory",
                "textContent": "Can be sold to the public provided it is licensed and labelled for the prophylaxis of malaria.",
                "html": "<p>Can be sold to the public provided it is licensed and labelled for the prophylaxis of malaria. </p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral solution",
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76488",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP98624",
                "label": "CHLOROQUINE WITH PROGUANIL",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP97237",
                "label": "Adverse reactions to drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78098",
                "label": "Antimalarials",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78102",
                "label": "Malaria, prophylaxis",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_339",
                "label": "Proguanil",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76488",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}